BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/29/2014 7:34:00 PM | Browse: 1315 | Download: 1300
 |
Received |
|
2014-02-26 10:31 |
 |
Peer-Review Started |
|
2014-02-27 22:08 |
 |
To Make the First Decision |
|
2014-03-27 21:06 |
 |
Return for Revision |
|
2014-03-31 10:15 |
 |
Revised |
|
2014-04-29 00:00 |
 |
Second Decision |
|
2014-05-26 21:33 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-05-26 21:54 |
 |
Articles in Press |
|
2014-05-26 22:08 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-10-16 14:49 |
 |
Publish the Manuscript Online |
|
2014-10-29 19:34 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Adjuvant therapy in pancreatic cancer
|
Manuscript Source |
Invited Manuscript |
All Author List |
Owain Peris Jones, James Daniel Melling and Paula Ghaneh |
Funding Agency and Grant Number |
|
Corresponding Author |
Paula Ghaneh, Professor, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, 5th Floor UCD Building, Daulby Street, Liverpool L69 3GA, United Kingdom. p.ghaneh@liverpool.ac.uk |
Key Words |
Pancreatic cancer; Adjuvant; Gemcitabine; Chemotherapy; Chemoradiotherapy; Phase Ⅲ |
Core Tip |
This paper discusses every major trial undertaken in the field of adjuvant therapy in pancreatic cancer. The evolution of chemotherapeutic regimes over the past 25 years and the controversy surrounding chemoradiation are analysed, in addition to looking at the phase Ⅲ trials currently in progress. |
Publish Date |
2014-10-29 19:34 |
Citation |
Jones OP, Melling JD, Ghaneh P. Adjuvant therapy in pancreatic cancer. World J Gastroenterol 2014; 20(40): 14733-14746 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i40/14733.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i40.14733 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345